 | • レポートコード：MRC2-11QY03652 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は癌支持療法薬のグローバル市場について調査・分析したレポートです。種類別（制吐薬、エリスロポエチン刺激剤、顆粒球刺激剤、鎮痛剤、その他）市場規模、用途別（化学療法誘発性貧血、CINV、骨転移、癌性疼痛、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別癌支持療法薬の競争状況、市場シェア ・世界の癌支持療法薬市場：種類別市場規模 2015年-2020年（制吐薬、エリスロポエチン刺激剤、顆粒球刺激剤、鎮痛剤、その他） ・世界の癌支持療法薬市場：種類別市場規模予測 2021年-2026年（制吐薬、エリスロポエチン刺激剤、顆粒球刺激剤、鎮痛剤、その他） ・世界の癌支持療法薬市場：用途別市場規模 2015年-2020年（化学療法誘発性貧血、CINV、骨転移、癌性疼痛、その他） ・世界の癌支持療法薬市場：用途別市場規模予測 2021年-2026年（化学療法誘発性貧血、CINV、骨転移、癌性疼痛、その他） ・北米の癌支持療法薬市場分析：米国、カナダ ・ヨーロッパの癌支持療法薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの癌支持療法薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の癌支持療法薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの癌支持療法薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amgen、Helsinn Healthcare、Johnson &Johnson、Merck、F. Hoffmann-La Roche、GlaxoSmithKline、Heron Therapeutics、Kyowa Hakko Kirin、Novartis、TESARO、Teva Pharmaceutical Industries ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Cancer Supportive Care Medicine Market
The global Cancer Supportive Care Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cancer Supportive Care Medicine Scope and Market Size
Cancer Supportive Care Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Supportive Care Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cancer Supportive Care Medicine market is segmented into
Antiemetic Drugs
Erythropoietin-Stimulating Agents
Granulocyte-Stimulating Agents
Analgesics
Others
Segment by Application, the Cancer Supportive Care Medicine market is segmented into
Chemotherapy-Induced Anemia
CINV
Bone Metastasis
Cancer Pain
Other
Regional and Country-level Analysis
The Cancer Supportive Care Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Supportive Care Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Supportive Care Medicine Market Share Analysis
Cancer Supportive Care Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Supportive Care Medicine business, the date to enter into the Cancer Supportive Care Medicine market, Cancer Supportive Care Medicine product introduction, recent developments, etc.
The major vendors covered:
Amgen
Helsinn Healthcare
Johnson &Johnson
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
Heron Therapeutics
Kyowa Hakko Kirin
Novartis
TESARO
Teva Pharmaceutical Industries
1 Study Coverage
1.1 Cancer Supportive Care Medicine Product Introduction
1.2 Market Segments
1.3 Key Cancer Supportive Care Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Supportive Care Medicine Market Size Growth Rate by Type
1.4.2 Antiemetic Drugs
1.4.3 Erythropoietin-Stimulating Agents
1.4.4 Granulocyte-Stimulating Agents
1.4.5 Analgesics
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cancer Supportive Care Medicine Market Size Growth Rate by Application
1.5.2 Chemotherapy-Induced Anemia
1.5.3 CINV
1.5.4 Bone Metastasis
1.5.5 Cancer Pain
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Supportive Care Medicine Market Size, Estimates and Forecasts
2.1.1 Global Cancer Supportive Care Medicine Revenue 2015-2026
2.1.2 Global Cancer Supportive Care Medicine Sales 2015-2026
2.2 Global Cancer Supportive Care Medicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cancer Supportive Care Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cancer Supportive Care Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cancer Supportive Care Medicine Competitor Landscape by Players
3.1 Cancer Supportive Care Medicine Sales by Manufacturers
3.1.1 Cancer Supportive Care Medicine Sales by Manufacturers (2015-2020)
3.1.2 Cancer Supportive Care Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Cancer Supportive Care Medicine Revenue by Manufacturers
3.2.1 Cancer Supportive Care Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Cancer Supportive Care Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Supportive Care Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Supportive Care Medicine Revenue in 2019
3.2.5 Global Cancer Supportive Care Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cancer Supportive Care Medicine Price by Manufacturers
3.4 Cancer Supportive Care Medicine Manufacturing Base Distribution, Product Types
3.4.1 Cancer Supportive Care Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Supportive Care Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Supportive Care Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Supportive Care Medicine Market Size by Type (2015-2020)
4.1.1 Global Cancer Supportive Care Medicine Sales by Type (2015-2020)
4.1.2 Global Cancer Supportive Care Medicine Revenue by Type (2015-2020)
4.1.3 Cancer Supportive Care Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Supportive Care Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Supportive Care Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Supportive Care Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Supportive Care Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Supportive Care Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Supportive Care Medicine Market Size by Application (2015-2020)
5.1.1 Global Cancer Supportive Care Medicine Sales by Application (2015-2020)
5.1.2 Global Cancer Supportive Care Medicine Revenue by Application (2015-2020)
5.1.3 Cancer Supportive Care Medicine Price by Application (2015-2020)
5.2 Cancer Supportive Care Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Supportive Care Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Supportive Care Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Supportive Care Medicine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cancer Supportive Care Medicine by Country
6.1.1 North America Cancer Supportive Care Medicine Sales by Country
6.1.2 North America Cancer Supportive Care Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cancer Supportive Care Medicine Market Facts & Figures by Type
6.3 North America Cancer Supportive Care Medicine Market Facts & Figures by Application
7 Europe
7.1 Europe Cancer Supportive Care Medicine by Country
7.1.1 Europe Cancer Supportive Care Medicine Sales by Country
7.1.2 Europe Cancer Supportive Care Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Supportive Care Medicine Market Facts & Figures by Type
7.3 Europe Cancer Supportive Care Medicine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cancer Supportive Care Medicine by Region
8.1.1 Asia Pacific Cancer Supportive Care Medicine Sales by Region
8.1.2 Asia Pacific Cancer Supportive Care Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cancer Supportive Care Medicine Market Facts & Figures by Type
8.3 Asia Pacific Cancer Supportive Care Medicine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cancer Supportive Care Medicine by Country
9.1.1 Latin America Cancer Supportive Care Medicine Sales by Country
9.1.2 Latin America Cancer Supportive Care Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cancer Supportive Care Medicine Market Facts & Figures by Type
9.3 Central & South America Cancer Supportive Care Medicine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cancer Supportive Care Medicine by Country
10.1.1 Middle East and Africa Cancer Supportive Care Medicine Sales by Country
10.1.2 Middle East and Africa Cancer Supportive Care Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cancer Supportive Care Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Cancer Supportive Care Medicine Market Facts & Figures by Application
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description and Business Overview
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Cancer Supportive Care Medicine Products Offered
11.1.5 Amgen Related Developments
11.2 Helsinn Healthcare
11.2.1 Helsinn Healthcare Corporation Information
11.2.2 Helsinn Healthcare Description and Business Overview
11.2.3 Helsinn Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Helsinn Healthcare Cancer Supportive Care Medicine Products Offered
11.2.5 Helsinn Healthcare Related Developments
11.3 Johnson &Johnson
11.3.1 Johnson &Johnson Corporation Information
11.3.2 Johnson &Johnson Description and Business Overview
11.3.3 Johnson &Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson &Johnson Cancer Supportive Care Medicine Products Offered
11.3.5 Johnson &Johnson Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Cancer Supportive Care Medicine Products Offered
11.4.5 Merck Related Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Corporation Information
11.5.2 F. Hoffmann-La Roche Description and Business Overview
11.5.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F. Hoffmann-La Roche Cancer Supportive Care Medicine Products Offered
11.5.5 F. Hoffmann-La Roche Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Cancer Supportive Care Medicine Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Heron Therapeutics
11.7.1 Heron Therapeutics Corporation Information
11.7.2 Heron Therapeutics Description and Business Overview
11.7.3 Heron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Heron Therapeutics Cancer Supportive Care Medicine Products Offered
11.7.5 Heron Therapeutics Related Developments
11.8 Kyowa Hakko Kirin
11.8.1 Kyowa Hakko Kirin Corporation Information
11.8.2 Kyowa Hakko Kirin Description and Business Overview
11.8.3 Kyowa Hakko Kirin Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Kyowa Hakko Kirin Cancer Supportive Care Medicine Products Offered
11.8.5 Kyowa Hakko Kirin Related Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Description and Business Overview
11.9.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis Cancer Supportive Care Medicine Products Offered
11.9.5 Novartis Related Developments
11.10 TESARO
11.10.1 TESARO Corporation Information
11.10.2 TESARO Description and Business Overview
11.10.3 TESARO Sales, Revenue and Gross Margin (2015-2020)
11.10.4 TESARO Cancer Supportive Care Medicine Products Offered
11.10.5 TESARO Related Developments
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description and Business Overview
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Cancer Supportive Care Medicine Products Offered
11.1.5 Amgen Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cancer Supportive Care Medicine Market Estimates and Projections by Region
12.1.1 Global Cancer Supportive Care Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Cancer Supportive Care Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Cancer Supportive Care Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Cancer Supportive Care Medicine Sales Forecast (2021-2026)
12.2.2 North America: Cancer Supportive Care Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Cancer Supportive Care Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Cancer Supportive Care Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Cancer Supportive Care Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Cancer Supportive Care Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Cancer Supportive Care Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cancer Supportive Care Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cancer Supportive Care Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cancer Supportive Care Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cancer Supportive Care Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Cancer Supportive Care Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Cancer Supportive Care Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Cancer Supportive Care Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Cancer Supportive Care Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cancer Supportive Care Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cancer Supportive Care Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cancer Supportive Care Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cancer Supportive Care Medicine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Supportive Care Medicine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Supportive Care Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cancer Supportive Care Medicine Market Segments
Table 2. Ranking of Global Top Cancer Supportive Care Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cancer Supportive Care Medicine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Antiemetic Drugs
Table 5. Major Manufacturers of Erythropoietin-Stimulating Agents
Table 6. Major Manufacturers of Granulocyte-Stimulating Agents
Table 7. Major Manufacturers of Analgesics
Table 8. Major Manufacturers of Others
Table 9. Global Cancer Supportive Care Medicine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global Cancer Supportive Care Medicine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global Cancer Supportive Care Medicine Sales by Regions 2015-2020 (K MT)
Table 12. Global Cancer Supportive Care Medicine Sales Market Share by Regions (2015-2020)
Table 13. Global Cancer Supportive Care Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Cancer Supportive Care Medicine Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Cancer Supportive Care Medicine Sales Share by Manufacturers (2015-2020)
Table 16. Global Cancer Supportive Care Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Cancer Supportive Care Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Supportive Care Medicine as of 2019)
Table 18. Cancer Supportive Care Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Cancer Supportive Care Medicine Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Cancer Supportive Care Medicine Price (2015-2020) (USD/MT)
Table 21. Cancer Supportive Care Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Cancer Supportive Care Medicine Product Type
Table 23. Date of International Manufacturers Enter into Cancer Supportive Care Medicine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Supportive Care Medicine Sales by Type (2015-2020) (K MT)
Table 26. Global Cancer Supportive Care Medicine Sales Share by Type (2015-2020)
Table 27. Global Cancer Supportive Care Medicine Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Cancer Supportive Care Medicine Revenue Share by Type (2015-2020)
Table 29. Cancer Supportive Care Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Cancer Supportive Care Medicine Sales by Application (2015-2020) (K MT)
Table 31. Global Cancer Supportive Care Medicine Sales Share by Application (2015-2020)
Table 32. North America Cancer Supportive Care Medicine Sales by Country (2015-2020) (K MT)
Table 33. North America Cancer Supportive Care Medicine Sales Market Share by Country (2015-2020)
Table 34. North America Cancer Supportive Care Medicine Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Cancer Supportive Care Medicine Revenue Market Share by Country (2015-2020)
Table 36. North America Cancer Supportive Care Medicine Sales by Type (2015-2020) (K MT)
Table 37. North America Cancer Supportive Care Medicine Sales Market Share by Type (2015-2020)
Table 38. North America Cancer Supportive Care Medicine Sales by Application (2015-2020) (K MT)
Table 39. North America Cancer Supportive Care Medicine Sales Market Share by Application (2015-2020)
Table 40. Europe Cancer Supportive Care Medicine Sales by Country (2015-2020) (K MT)
Table 41. Europe Cancer Supportive Care Medicine Sales Market Share by Country (2015-2020)
Table 42. Europe Cancer Supportive Care Medicine Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Cancer Supportive Care Medicine Revenue Market Share by Country (2015-2020)
Table 44. Europe Cancer Supportive Care Medicine Sales by Type (2015-2020) (K MT)
Table 45. Europe Cancer Supportive Care Medicine Sales Market Share by Type (2015-2020)
Table 46. Europe Cancer Supportive Care Medicine Sales by Application (2015-2020) (K MT)
Table 47. Europe Cancer Supportive Care Medicine Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Cancer Supportive Care Medicine Sales by Region (2015-2020) (K MT)
Table 49. Asia Pacific Cancer Supportive Care Medicine Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Cancer Supportive Care Medicine Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Cancer Supportive Care Medicine Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Cancer Supportive Care Medicine Sales by Type (2015-2020) (K MT)
Table 53. Asia Pacific Cancer Supportive Care Medicine Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Cancer Supportive Care Medicine Sales by Application (2015-2020) (K MT)
Table 55. Asia Pacific Cancer Supportive Care Medicine Sales Market Share by Application (2015-2020)
Table 56. Latin America Cancer Supportive Care Medicine Sales by Country (2015-2020) (K MT)
Table 57. Latin America Cancer Supportive Care Medicine Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Cancer Supportive Care Medicine Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Cancer Supportive Care Medicine Revenue Market Share by Country (2015-2020)
Table 60. Latin America Cancer Supportive Care Medicine Sales by Type (2015-2020) (K MT)
Table 61. Latin America Cancer Supportive Care Medicine Sales Market Share by Type (2015-2020)
Table 62. Latin America Cancer Supportive Care Medicine Sales by Application (2015-2020) (K MT)
Table 63. Latin America Cancer Supportive Care Medicine Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Cancer Supportive Care Medicine Sales by Country (2015-2020) (K MT)
Table 65. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Cancer Supportive Care Medicine Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Cancer Supportive Care Medicine Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Cancer Supportive Care Medicine Sales by Type (2015-2020) (K MT)
Table 69. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Cancer Supportive Care Medicine Sales by Application (2015-2020) (K MT)
Table 71. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share by Application (2015-2020)
Table 72. Amgen Corporation Information
Table 73. Amgen Description and Major Businesses
Table 74. Amgen Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. Amgen Product
Table 76. Amgen Recent Development
Table 77. Helsinn Healthcare Corporation Information
Table 78. Helsinn Healthcare Description and Major Businesses
Table 79. Helsinn Healthcare Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Helsinn Healthcare Product
Table 81. Helsinn Healthcare Recent Development
Table 82. Johnson &Johnson Corporation Information
Table 83. Johnson &Johnson Description and Major Businesses
Table 84. Johnson &Johnson Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Johnson &Johnson Product
Table 86. Johnson &Johnson Recent Development
Table 87. Merck Corporation Information
Table 88. Merck Description and Major Businesses
Table 89. Merck Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Merck Product
Table 91. Merck Recent Development
Table 92. F. Hoffmann-La Roche Corporation Information
Table 93. F. Hoffmann-La Roche Description and Major Businesses
Table 94. F. Hoffmann-La Roche Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. F. Hoffmann-La Roche Product
Table 96. F. Hoffmann-La Roche Recent Development
Table 97. GlaxoSmithKline Corporation Information
Table 98. GlaxoSmithKline Description and Major Businesses
Table 99. GlaxoSmithKline Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. GlaxoSmithKline Product
Table 101. GlaxoSmithKline Recent Development
Table 102. Heron Therapeutics Corporation Information
Table 103. Heron Therapeutics Description and Major Businesses
Table 104. Heron Therapeutics Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Heron Therapeutics Product
Table 106. Heron Therapeutics Recent Development
Table 107. Kyowa Hakko Kirin Corporation Information
Table 108. Kyowa Hakko Kirin Description and Major Businesses
Table 109. Kyowa Hakko Kirin Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Kyowa Hakko Kirin Product
Table 111. Kyowa Hakko Kirin Recent Development
Table 112. Novartis Corporation Information
Table 113. Novartis Description and Major Businesses
Table 114. Novartis Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Novartis Product
Table 116. Novartis Recent Development
Table 117. TESARO Corporation Information
Table 118. TESARO Description and Major Businesses
Table 119. TESARO Cancer Supportive Care Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. TESARO Product
Table 121. TESARO Recent Development
Table 122. Teva Pharmaceutical Industries Corporation Information
Table 123. Teva Pharmaceutical Industries Description and Major Businesses
Table 124. Teva Pharmaceutical Industries Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Teva Pharmaceutical Industries Product
Table 126. Teva Pharmaceutical Industries Recent Development
Table 127. Global Cancer Supportive Care Medicine Sales Forecast by Regions (2021-2026) (K MT)
Table 128. Global Cancer Supportive Care Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Cancer Supportive Care Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Cancer Supportive Care Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Cancer Supportive Care Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 132. North America: Cancer Supportive Care Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Cancer Supportive Care Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 134. Europe: Cancer Supportive Care Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Cancer Supportive Care Medicine Sales Forecast by Region (2021-2026) (K MT)
Table 136. Asia Pacific: Cancer Supportive Care Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Cancer Supportive Care Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 138. Latin America: Cancer Supportive Care Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Cancer Supportive Care Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 140. Middle East and Africa: Cancer Supportive Care Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Cancer Supportive Care Medicine Players
Table 145. Cancer Supportive Care Medicine Customers List
Table 146. Cancer Supportive Care Medicine Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Supportive Care Medicine Product Picture
Figure 2. Global Cancer Supportive Care Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Antiemetic Drugs Product Picture
Figure 4. Erythropoietin-Stimulating Agents Product Picture
Figure 5. Granulocyte-Stimulating Agents Product Picture
Figure 6. Analgesics Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cancer Supportive Care Medicine Sales Market Share by Application in 2020 & 2026
Figure 9. Chemotherapy-Induced Anemia
Figure 10. CINV
Figure 11. Bone Metastasis
Figure 12. Cancer Pain
Figure 13. Other
Figure 14. Cancer Supportive Care Medicine Report Years Considered
Figure 15. Global Cancer Supportive Care Medicine Market Size 2015-2026 (US$ Million)
Figure 16. Global Cancer Supportive Care Medicine Sales 2015-2026 (K MT)
Figure 17. Global Cancer Supportive Care Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Cancer Supportive Care Medicine Sales Market Share by Region (2015-2020)
Figure 19. Global Cancer Supportive Care Medicine Sales Market Share by Region in 2019
Figure 20. Global Cancer Supportive Care Medicine Revenue Market Share by Region (2015-2020)
Figure 21. Global Cancer Supportive Care Medicine Revenue Market Share by Region in 2019
Figure 22. Global Cancer Supportive Care Medicine Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Cancer Supportive Care Medicine Revenue in 2019
Figure 24. Cancer Supportive Care Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Cancer Supportive Care Medicine Sales Market Share by Type (2015-2020)
Figure 26. Global Cancer Supportive Care Medicine Sales Market Share by Type in 2019
Figure 27. Global Cancer Supportive Care Medicine Revenue Market Share by Type (2015-2020)
Figure 28. Global Cancer Supportive Care Medicine Revenue Market Share by Type in 2019
Figure 29. Global Cancer Supportive Care Medicine Market Share by Price Range (2015-2020)
Figure 30. Global Cancer Supportive Care Medicine Sales Market Share by Application (2015-2020)
Figure 31. Global Cancer Supportive Care Medicine Sales Market Share by Application in 2019
Figure 32. Global Cancer Supportive Care Medicine Revenue Market Share by Application (2015-2020)
Figure 33. Global Cancer Supportive Care Medicine Revenue Market Share by Application in 2019
Figure 34. North America Cancer Supportive Care Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 35. North America Cancer Supportive Care Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Cancer Supportive Care Medicine Sales Market Share by Country in 2019
Figure 37. North America Cancer Supportive Care Medicine Revenue Market Share by Country in 2019
Figure 38. U.S. Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 39. U.S. Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 41. Canada Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Cancer Supportive Care Medicine Market Share by Type in 2019
Figure 43. North America Cancer Supportive Care Medicine Market Share by Application in 2019
Figure 44. Europe Cancer Supportive Care Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 45. Europe Cancer Supportive Care Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Cancer Supportive Care Medicine Sales Market Share by Country in 2019
Figure 47. Europe Cancer Supportive Care Medicine Revenue Market Share by Country in 2019
Figure 48. Germany Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 49. Germany Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 51. France Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 53. U.K. Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 55. Italy Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 57. Russia Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Cancer Supportive Care Medicine Market Share by Type in 2019
Figure 59. Europe Cancer Supportive Care Medicine Market Share by Application in 2019
Figure 60. Asia Pacific Cancer Supportive Care Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 61. Asia Pacific Cancer Supportive Care Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Cancer Supportive Care Medicine Sales Market Share by Region in 2019
Figure 63. Asia Pacific Cancer Supportive Care Medicine Revenue Market Share by Region in 2019
Figure 64. China Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 65. China Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 67. Japan Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 69. South Korea Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 71. India Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 73. Australia Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 75. Taiwan Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 77. Indonesia Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 79. Thailand Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 81. Malaysia Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 83. Philippines Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 85. Vietnam Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Cancer Supportive Care Medicine Market Share by Type in 2019
Figure 87. Asia Pacific Cancer Supportive Care Medicine Market Share by Application in 2019
Figure 88. Latin America Cancer Supportive Care Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 89. Latin America Cancer Supportive Care Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Cancer Supportive Care Medicine Sales Market Share by Country in 2019
Figure 91. Latin America Cancer Supportive Care Medicine Revenue Market Share by Country in 2019
Figure 92. Mexico Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 93. Mexico Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 95. Brazil Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 97. Argentina Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Cancer Supportive Care Medicine Market Share by Type in 2019
Figure 99. Latin America Cancer Supportive Care Medicine Market Share by Application in 2019
Figure 100. Middle East and Africa Cancer Supportive Care Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 101. Middle East and Africa Cancer Supportive Care Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Cancer Supportive Care Medicine Revenue Market Share by Country in 2019
Figure 104. Turkey Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 105. Turkey Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 107. Saudi Arabia Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Cancer Supportive Care Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 109. U.A.E Cancer Supportive Care Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Cancer Supportive Care Medicine Market Share by Type in 2019
Figure 111. Middle East and Africa Cancer Supportive Care Medicine Market Share by Application in 2019
Figure 112. North America Cancer Supportive Care Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. North America Cancer Supportive Care Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Cancer Supportive Care Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Europe Cancer Supportive Care Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Cancer Supportive Care Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Asia Pacific Cancer Supportive Care Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Cancer Supportive Care Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Latin America Cancer Supportive Care Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Cancer Supportive Care Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Middle East and Africa Cancer Supportive Care Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
がん支持療法の世界市場（～2026年） The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. With growing prevalence of cancer…- 前立腺がん治療薬の世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise…
- ゲノム医療の世界市場（～2026年） Market Analysis and Insights: Global Genomic Medicine Market The global Genomic Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Genomic Medicine Scope and Market Size Genomic Medicine market is segmented by Ty…
- がん治療におけるゲノミクスの世界市場（～2026年） Use genomic knowledge to keep prevention of cancer Growing demand for diagnostics coupled with availability of technologically advanced and cost efficient diagnostic technology is expected to fuel the market growth in coming years. Market Analysis and Insights: Global Genomics In Cancer Care Market …
- 老年医学の世界市場（～2026年） Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults One of the key factors attributing to its rapid growth include rapidly increasing geriatric population base.…